Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Aktiia® launches into healthcare market with $17.5M investment for its world-first 24-7 Blood Pressure Monitoring System


News provided by

Aktiia

03 Nov, 2021, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

NEUCHATEL, Switzerland, Nov. 3, 2021 /PRNewswire/ -- Hypertension health-tech firm Aktiia today announced a $17.5M Series A round of funding that will be used to accelerate its expansion in the NHS and in health systems across Europe. The funding is led by UK-based venture capital firm Draper Esprit, with additional participation from Germany's 415 CAPITAL, Switzerland's Redalpine Venture Partners and Verve Capital, and Silicon Valley based Translink Capital.

Aktiia's revolutionary 24-7 automated blood pressure monitoring system enables stress-free reading round the clock, and has the potential to transform the diagnosis and treatment of hypertension, which affects approximately 1.28 billion adults worldwide and is a leading cause of premature death.

Aktiia already has tens of thousands of consumers across the UK, Ireland, Germany, Austria, France, Switzerland, and Italy. This Series A will be used to expand its offer to healthcare systems within these geographies as well as moving into new territories.

In addition to endorsement by leading clinicians in hypertension management, Aktiia is now also an official partner of the International Society of Hypertension. It's huge potential was further underlined  this week when leading peer-reviewed scientific journal Nature Scientific Reports published Aktiia's clinical trial,  which validated the optical bracelet in different body positions for the persistent monitoring of blood pressure, cementing Aktiia as a solution for the real-life phenotyping of patients according to individual blood pressure pattern. As nighttime blood pressure measurements are the strongest predictor of cardiovascular risk, and Aktiia is the only easy 24/7 solution that enables these measurements without cuff inflation, this is an incredibly exciting moment for hypertension diagnostics.

Since launch in Spring 2021, Aktiia now has tens of thousands of users, who on average check their blood pressure data over sixteen times a week, with an average of 150 weekly readings performed by the device automatically in the background. The data is then visualized in a free companion application; with a simple click, a digital summary can be easily shared with a physician or family member. In contrast, the average hypertensive patient currently measures their blood pressure only once per week due to the inconvenience and discomfort associated with a traditional cuff. Combined with white coat hypertension, masked hypertension, and other common issues with in-office diagnosis, this sporadic at-home monitoring can lead to poor management and delays in optimising treatment. 

The brand is expanding its commercial footprint in key healthcare markets across Europe and the globe, starting with the appointment of new Head of European Healthcare Sales and Partnerships Richard Cardow, a twenty-year veteran of the cardiovascular monitoring industry. 

Aktiia has been validated in multiple clinical studies, with the results of its pivotal clinical trial peer-reviewed and published in "Nature Scientific Reports" and "Blood Pressure Monitoring" and it has received a CE Mark as a Class IIa medical device. Aktiia has also gained endorsement from several top clinicians in the field: 

"I believe we are only scratching the surface of the possible applications for the long-term 24/7 blood pressure data that Aktiia is uniquely capable of providing to physicians," stated Professor Melvin Lobo, NHS Professor of Cardiovascular Medicine and Director of St. Bartholomew's Hospital Blood Pressure Clinic. "This is an indisputable game changer in enabling a better understanding of our patients' blood pressure patterns and how to treat them on a personalized basis." 

Notes to editors

How It Works 

Aktiia's Optical Blood Pressure Monitoring (OBPMTM) algorithms leverage optical sensors worn on the wrist and provide blood pressure values using photoplethysmography (PPG) to analyze the changing diameter of the arteries occurring at each heartbeat. This optical measurement is done automatically, so users are not aware and stressed, and do not have to interrupt their day or their sleep to take a measurement. 

About Aktiia:  Founded in Switzerland in May 2018, Aktiia's team has some of the world's leading scientific and technical experts in optical blood pressure monitoring, including CTO, Dr. Josep Sola, a pioneer in cuffless blood pressure monitoring and editor of "The Handbook of Cuffless Blood Pressure Monitoring." The core technology was first developed over decades of research at the prestigious Swiss Center for Electronics and Microtechnology (CSEM), under a team lead by Aktiia co-founders, Dr. Mattia Bertschi and Dr. Josep Sola. 

"At Aktiia, we believe the key to improving cardiovascular health is to provide patients and physicians a deeper understanding of their blood pressure pattern," said Mike Kisch, Aktiia CEO. "Before Aktiia, it was not possible to do this at scale. We are excited about expanding access to this technology and the positive impact it can have on reducing major adverse cardiovascular events." 

Pricing & Availability 

Aktiia is available for purchase now in the UK, Ireland, Germany, Austria, Switzerland, France, and Italy via Aktiia.com for £199.99 / €199.99 / CHF219.99. The Aktiia bracelet, the Aktiia cuff (used for initialization once per month), and the Aktiia 24/7 Blood Pressure Monitoring service are all included in the price. Users maintain ownership of devices, and continue to have ongoing free access to their data and the essential feature set. 

To learn more, visit Aktiia.com. 

Download the press kit here.

Media Contact for Aktiia: 
Ana Hoyos
ZPB Associates 
07849089456
ana.hoyos@zpb-associates.com

Modal title

Also from this source

Aktiia secures $42 million in Series B funding round and rebrands to Hilo

Aktiia secures $42 million in Series B funding round and rebrands to Hilo

Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by...

Health Canada Approves Aktiia Bracelet: First Consumer Blood Pressure Wearable for Canadians To Take Accurate, Automated Readings Up To 50 Times A Day

Aktiia, the Swiss HealthTech specializing in cuffless blood pressure monitoring technology, today announced the launch of its continuous blood...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Banking & Financial Services

Banking & Financial Services

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.